Conference

More Information

Therapeutic Antibodies Broshure
Book online today

Therapeutic Antibodies Europe 2010 Advisory Board

These seasoned industry professionals volunteer their time to help construct the conference sessions. They work to ensure that the quality of the content and solutions provided to attendees is of a high-level, relevant, and timely. Their dedication is critical to the success of the conference. Read below to find out about the extraordinary members of the Advisory Board.

Advisory board 


Andrew Nixon
Vice President of
Discovery Research
Dyax
Andrew Nixon

Dr. Nixon is vice president of discovery research at Dyax, responsible for Lead Discovery & Biochemistry activities within the discovery research group. In this role he oversees all aspects of Dyax’s phage display technology including library selections, isolate screening, and the production and characterization of selected leads. Prior to joining Dyax in 1999, Dr. Nixon completed a post-doctoral fellowship in the laboratory of Prof. S.J. Benkovic, in the Department of Chemistry at Pennsylvania State University, where he was involved in the development of techniques to facilitate enzyme engineering. Dr. Nixon earned his Ph.D. from the University of London for studies completed at the MRC’s National Institute for Medical Research.


Dr. Dragan Grabulovski

CSO, Covagen
Dr. Dragan Grabulovski

Dr. Hanjo Hennemann

CSO and CEO
Nexigen GmbH
Dr. Hanjo Hennemann
LinkedIn
LONZA
Quotient Bio Research
http://www.pall.com/
http://www.px-therapeutics.com/
Quality Assistance
Genscript